More clinical research should investigate the effectiveness across different patient conditions, but the existing evidence suggests the treatments are generally safe, well tolerated, and worth trying for those struggling with chronic pain or steroid side effects
Currently, allopathic (versus functional medicine) Crohns disease treatment, for example- starts off with with brain and gut damaging corticosteroids and 5-aminosalicylic acid products, adds immunomodulators (Azathioprine, 6-mercaptopurine, methotrexate), and eventually, biological agents which are TNF-alpha inhibitors (infliximab, adalimumab, certolizumab, and golimumab)
These are perfect to flaunt that juicy pout
A surge in demand for GLP-1 receptor agonist drugs such as Ozempic has transformed them from treatments primarily for type 2 diabetes into popular weight-loss medications, fueling shortages, cultural trends, and now thousands of lawsuits alleging serious side effects
LCS3 is a synergistic inhibitor of GSR and TXNRD1
An increase in the production of pro-inflammatory chemokines and cytokines such as C-C motif chemokine ligand 2, TNF-, IL-1 and IL-6, as well as a decrease in the expression of the key insulin-sensitizing adipokine, adiponectin, is associated with the infiltration of pro-inflammatory cells into adipose tissue
